INFOGRAPHIC | NOV 25, 2025

Scrip Asia 100 logo with the Citeline Commercial tagline underneath.

Asia’s biopharma sector is rewriting the global innovation story. From China’s rapid rise as an R&D powerhouse to South Korea’s dynamic deal-making, the Scrip Asia 100 captures the region’s transformation in vivid detail.

This exclusive infographic distils the key insights from the 2026 Scrip Asia 100 ranking, spotlighting the top companies by 2024 sales, regional highlights, and the latest policy shifts driving innovation.

Download the infographic now and get instant access to the data, detail, and analysis behind Asia’s biopharma revolution.

''
Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

What's Inside
  • Top 5 Revealed: Instantly see Asia’s leading biopharma companies and who’s climbing the ranks.
  • Regional Hotspots: Get quick insights into China, Japan, India, and South Korea’s standout strategies.
  • Next-Gen Breakthroughs: Discover the innovative therapies and trends shaping global healthcare.